cisatracurium kalceks 2 mg/ml inj./inf. sol. i.v. amp.
as kalceks a.s. - cisatracurium besilate 2,68 mg/ml - eq. cisatracurium 2 mg/ml - solution for injection/infusion - 2 mg/ml - cisatracurium besilate 2.68 mg/ml - cisatracurium
cisatracurium kalceks 2 mg/ml inj./inf. sol. i.v. amp.
as kalceks a.s. - cisatracurium besilate 2,68 mg/ml - eq. cisatracurium 2 mg/ml - solution for injection/infusion - 2 mg/ml - cisatracurium besilate 2.68 mg/ml - cisatracurium
cisatracurium sandoz 2 mg/ml inj./inf. sol. i.v. amp.
sandoz sa-nv - cisatracurium besilate 2,68 mg/ml - eq. cisatracurium 2 mg/ml - solution for injection/infusion - 2 mg/ml - cisatracurium besilate 2.68 mg/ml - cisatracurium
cisatracurium sandoz 2 mg/ml inj./inf. sol. i.v. amp.
sandoz sa-nv - cisatracurium besilate 2,68 mg/ml - eq. cisatracurium 2 mg/ml - solution for injection/infusion - 2 mg/ml - cisatracurium besilate 2.68 mg/ml - cisatracurium
cisatracurium sandoz 2 mg/ml inj./inf. sol. i.v. amp.
sandoz sa-nv - cisatracurium besilate 2,68 mg/ml - eq. cisatracurium 2 mg/ml - solution for injection/infusion - 2 mg/ml - cisatracurium besilate 2.68 mg/ml - cisatracurium
cisatracurium accordpharma 2 mg/ml inj./inf. sol. i.v. vial
accord healthcare b.v. - cisatracurium besilate 2,68 mg/ml - eq. cisatracurium 2 mg/ml - solution for injection/infusion - 2 mg/ml - cisatracurium besilate 2.68 mg/ml - cisatracurium
cisatracurium accordpharma 2 mg/ml inj./inf. sol. i.v. vial
accord healthcare b.v. - cisatracurium besilate 2,68 mg/ml - eq. cisatracurium 2 mg/ml - solution for injection/infusion - 2 mg/ml - cisatracurium besilate 2.68 mg/ml - cisatracurium
cisatracurium accordpharma 2 mg/ml inj./inf. sol. i.v. vial
accord healthcare b.v. - cisatracurium besilate 2,68 mg/ml - eq. cisatracurium 2 mg/ml - solution for injection/infusion - 2 mg/ml - cisatracurium besilate 2.68 mg/ml - cisatracurium
dbl™ atracurium besylate injection
pfizer new zealand limited - atracurium besilate 10 mg/ml - solution for injection - 10 mg/ml - active: atracurium besilate 10 mg/ml excipient: benzenesulfonic acid water for injection - dbl™ atracurium besylate injection is indicated as an adjunct to general anaesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
hospira atracurium besilate 10 mg/ml solution for injection 250 mg/25 ml vial
hospira australia pty ltd - atracurium besilate, quantity: 10.5 mg/ml - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - indications for the united kingdom: atracurium besilate solution for injection is a medicine which acts as a muscle relaxant. atracurium besilate solution for injection is used during surgery to relax muscles and to assist with inserting a breathing tube and with artificial breathing. it is also used to help with artificial breathing in patients in intensive care. indications for france: the injection solution of atracurium is used during surgery to relax the muscles as well as to facilitate the intubation of the endotracheal and assisted ventilation. it is also used to allow artificial ventilation in patients in intensive care.